Smith+Nephew (S+N) welcomes the opportunity to comment on the EU Commissions proposal to strengthen competitiveness of the Medical Device sector and improve safety requirements by making them more cost-effective and proportionate. S+N particularly supports the proposed measures on digitalisation (Article 52b) and reliance/recognition (Article 108).
SN
Smith+Nephew
Company · United Kingdom
2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track Smith+Nephew in PolicySpeak: request access →
Work at Smith+Nephew? so we know who speaks for it.
Their record over time
Smith+Nephew filed 2 positions between 5 Oct 2025 and 28 Jul 2026, across 1 of the 326 legislative files tracked here.
2025 · 1 filed2026 · 1 filed
What they argued
Smith+Nephew welcomes the opportunity to provide feedback in support of the Commissions aims to make the medical device sector more competitive and make safety requirements more cost-efficient and proportionate.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Smith+Nephew’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.